Benjamine Liu

Benjamine Liu is the co-founder and CEO of Formation Bio, a biotechnology company focused on using AI and technology to improve drug development and clinical trials.12 Some key points about Liu:

Education and Early Career

• Graduated from Yale University, where he received the college's highest honor at graduation (the Alpheus Henry Snow Prize)12
• Earned an MPhil with distinction in Computational Biology from the University of Cambridge as a Paul Mellon Fellow1
• Received his DPhil (PhD) at Oxford University as a Rhodes Scholar, focusing on using machine learning and AI for developing diagnostics and therapeutics for Parkinson's and Alzheimer's disease12

Formation Bio

• Co-founded and currently serves as CEO of Formation Bio12
• The company aims to create a "pharma company of the future" driven by tech and AI to bring new treatments to patients faster and more efficiently1
• Liu was motivated to start Formation Bio after observing how clinical trials bottlenecked the development of new treatments during his graduate work1

Advisory Role

• Serves as an Advisor to Harvard Business School's MS/MBA Program in Biotechnology1

Achievements and Recognition

• Awarded the Barry M. Goldwater Scholarship for excellence in science and mathematics2
• Received the Josephine DeKarman Fellowship, recognizing excellence in research and scholarship2
• Participated in the World Economic Forum's Annual Meeting of New Champions in Science and Technology2

Liu's background combines expertise in computational biology, AI, and drug development, which he leverages in his role at Formation Bio and as an advisor to Harvard's MS/MBA Biotechnology program.